Home
| Databases
| WorldLII
| Search
| Feedback
Generic Top Level Domain Name (gTLD) Decisions |
G.D. Searle & Co. v. E.T. Corp
Claim Number: FA0209000124537
PARTIES
Complainant
is G.D. Searle & Co., Skokie,
IL, USA (“Complainant”) represented by Paul
D. McGrady, of Ladas & Parry. Respondent is E.T. Corp., St. Johns, AG (“Respondent”).
REGISTRAR AND DISPUTED DOMAIN NAME
The
domain name at issue is <trycelebrex.com>,
registered with Bulkregister.
PANEL
The
undersigned certifies that he has acted independently and impartially and to
the best of his knowledge has no known conflict in
serving as Panelist in this
proceeding.
James
A. Carmody, Esq., as Panelist.
PROCEDURAL HISTORY
Complainant
submitted a Complaint to the National Arbitration Forum (the “Forum”)
electronically on September 5, 2002; the Forum received
a hard copy of the Complaint
on September 6, 2002.
On
September 5, 2002, Bulkregister confirmed by e-mail to the Forum that the
domain name <trycelebrex.com>
is registered with Bulkregister and that Respondent is the current registrant
of the name. Bulkregister has verified that
Respondent is bound by the Bulkregister registration agreement and has thereby
agreed to resolve domain-name
disputes brought by third parties in accordance
with ICANN’s Uniform Domain Name Dispute Resolution Policy (the “Policy”).
On
September 6, 2002, a Notification of Complaint and Commencement of
Administrative Proceeding (the “Commencement Notification”),
setting a deadline
of September 26, 2002 by which Respondent could file a Response to the
Complaint, was transmitted to Respondent
via e-mail, post and fax, to all
entities and persons listed on Respondent’s registration as technical,
administrative and billing
contacts, and to postmaster@trycelebrex.com by
e-mail.
Having
received no Response from Respondent, using the same contact details and methods
as were used for the Commencement Notification,
the Forum transmitted to the
parties a Notification of Respondent Default.
On
October 14, 2002, pursuant to Complainant’s request to have the dispute decided
by a single-member Panel, the Forum appointed James
A. Carmody, Esq., as
Panelist.
Having
reviewed the communications records, the Administrative Panel (the “Panel”)
finds that the Forum has discharged its responsibility
under Paragraph 2(a) of
the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”) “to
employ reasonably available
means calculated to achieve actual notice to
Respondent.” Therefore, the Panel may
issue its decision based on the documents submitted and in accordance with the
ICANN Policy, ICANN Rules,
the Forum’s Supplemental Rules and any rules and
principles of law that the Panel deems applicable, without the benefit of any
Response
from Respondent.
RELIEF SOUGHT
Complainant
requests that the domain name be transferred from Respondent to Complainant.
PARTIES’ CONTENTIONS
A.
Complainant
The
<trycelebrex.com> domain name
is confusingly similar to Complainant’s CELEBREX mark.
Respondent
has no rights or legitimate interests in the <trycelebrex.com> domain name.
Respondent
registered and used the <trycelebrex.com>
domain name in bad faith.
B.
Respondent
Respondent failed to submit a Response in
this proceeding.
FINDINGS
Complainant owns a registered
trademark with the United States Patent and Trademark Office for the CELEBREX
mark (Reg. No. 2,307,888). In an effort
to proactively safeguard its rights in the CELEBREX mark, Complainant has filed
trademark applications in more than 112
countries around the world. Complainant fashioned the CELEBREX mark for
use in connection with its “pharmaceutical products in the nature of
anti-inflammatory
analgesics.”
Complainant began seeking trademark protection in 1998, when it filed
applications for registration in the United States on February
10, 1998 and
abroad on February 16, 1998.
Furthermore, Complainant has extensively
used the CELEBREX mark for the past four years on a global scale marketing and
distributing
its anti-arthritic medicine.
The CELEBREX anti-arthritic medicine has gained recognition by The
New York Times and Forbes magazine, each labeling the medicine a
“blockbuster arthritis drug” and “the $2 billion (sales) crown jewel in
[Complainant’s] new
portfolio,” respectively.
As evidenced by Complainant’s extensive use of the fanciful CELEBREX
mark in commerce and the attention given to the CELEBREX medicine,
the CELEBREX
mark is well-known in the United States and abroad.
Respondent registered the <trycelebrex.com> domain name on December 19, 1999. Respondent has not developed any use for the
domain name for the nearly three years of registration ownership.
DISCUSSION
Paragraph 15(a) of the Rules instructs this Panel to
“decide a complaint on the basis of the statements and documents submitted in
accordance with the Policy, these Rules and any rules and principles of law
that it deems applicable.”
In view
of Respondent's failure to submit a Response, the Panel shall decide this
administrative proceeding on the basis of the Complainant's
undisputed
representations pursuant to paragraphs 5(e), 14(a) and 15(a) of the Rules and
draw such inferences it considers appropriate
pursuant to paragraph 14(b) of
the Rules.
Paragraph
4(a) of the Policy requires that the Complainant must prove each of the
following three elements to obtain an order that
a domain name should be
cancelled or transferred:
(1) the domain name registered by Respondent
is identical or confusingly similar to a trademark or service mark in which
Complainant has
rights; and
(2)
Respondent has no rights or legitimate interests in respect of the domain name;
and
(3)
the domain name has been registered and is being used in bad faith.
Identical and/or Confusingly Similar
Complainant has established its rights in
the CELEBREX mark through proof of registration with the USPTO and extensive
use in commerce.
Respondent’s <trycelebrex.com> domain name contains Complainant’s entire
CELEBREX mark with the addition of the prefix “try.” The word “try” is suggestive of Complainant’s CELEBREX mark as it
promotes the use of the CELEBREX medication.
As such, the prefix has no distinctive quality and the CELEBREX mark
remains the dominant part of the domain name.
Therefore, Respondent’s <trycelebrex.com>
domain name is confusingly similar to Complainant’s mark. See Arthur Guinness Son & Co. (Dublin) Ltd. v. Healy/BOSTH, D2001-0026 (WIPO Mar. 23, 2001) (finding
confusing similarity where the domain name in dispute contains the identical
mark of Complainant
combined with a generic word or term); see also Sony Kabushiki Kaisha v. Inja, Kil,
D2000-1409 (WIPO Dec. 9, 2000) (finding that “[n]either the addition of an
ordinary descriptive word…nor the suffix ‘.com’ detract
from the overall
impression of the dominant part of the name in each case, namely the trademark
SONY” and thus Policy ¶ 4(a)(i) is
satisfied).
The Panel finds that Policy ¶ 4(a)(i) has
been satisfied.
Rights or Legitimate Interests
Complainant has successfully alleged a prima
facie case, including Complainant’s allegation that Respondent has no
rights or legitimate interests in the <trycelebrex.com>
domain name. Respondent has failed
to come forward and answer the Complaint.
Therefore, Respondent has not met its burden of establishing rights or
legitimate interests in the domain name, and the Panel presumes
Respondent has
no such rights. See Clerical Med. Inv. Group Ltd. v.
Clericalmedical.com, D2000-1228 (WIPO Nov. 28, 2000) (finding that under
certain circumstances the mere assertion by Complainant that Respondent has
no
right or legitimate interest is sufficient to shift the burden of proof to
Respondent to demonstrate that such a right or legitimate
interest does exist);
see also Pavillion Agency, Inc. v.
Greenhouse Agency Ltd., D2000-1221 (WIPO Dec. 4, 2000) (finding that
Respondents’ failure to respond can be construed as an admission that they have
no
legitimate interest in the domain names).
Furthermore, Respondent’s failure to
challenge Complainant’s contentions allows all reasonable inferences to be
drawn in favor of
Complainant, while accepting Complainant’s allegations as
true. See Vertical Solutions Mgmt., Inc. v. webnet-marketing, inc., FA 95095
(Nat. Arb. Forum July 31, 2000) (failure to respond allows all reasonable
inferences of fact in the allegations of Complainant
to be deemed true); see
also Talk City,
Inc. v. Robertson, D2000-0009 (WIPO Feb.
29, 2000) (“In the absence of a response, it is appropriate to accept as true
all allegations of the Complaint”).
Respondent has made no active use of the <trycelebrex.com> domain name
since it registered the domain name nearly three years ago. Respondent has not come forward to explain
the reason for holding registration rights in the domain name and not using it
to resolve
to a website with content.
Passively holding a domain name that incorporates another entity’s
trademark does not constitute a bona fide offering of goods or
services
pursuant to Policy ¶ 4(c)(i), nor does it represent a legitimate noncommercial
fair use pursuant to Policy ¶ 4(c)(iii).
See Pharmacia & Upjohn
AB v. Romero, D2000-1273 (WIPO Nov. 13, 2000) (finding no rights or
legitimate interests where Respondent failed to submit a Response to the
Complaint
and had made no use of the domain name in question); see also Vestel Elektronik Sanayi ve Ticaret AS v.
Kahveci, D2000-1244 (WIPO Nov. 11, 2000) (finding that “merely registering
the domain name is not sufficient to establish rights or legitimate
interests
for purposes of paragraph 4(a)(ii) of the Policy”); see also Ritz-Carlton Hotel v. Club Car Executive,
D2000-0611 (WIPO Sept. 18, 2000) (finding that prior to any notice of the
dispute, Respondent had not used the domain names in connection
with any type
of bona fide offering of goods and services).
Although Complainant licenses its
CELEBREX mark out for commercial use by other entities, Respondent has no such
express authorization
from Complainant.
In addition, Respondent has no business affiliation with Complainant and
therefore is not impliedly permitted to use the CELEBREX
mark. Respondent is only known to this Panel as
E.T. Corp., and there is no evidence that shows Respondent is commonly known by
the <trycelebrex.com> domain
name. Therefore, Respondent has no
rights or legitimate interests in the domain name pursuant to Policy ¶
4(c)(ii). See Compagnie de Saint Gobain v. Com-Union Corp.,
D2000-0020 (WIPO Mar. 14, 2000) (finding no rights or legitimate interest where
Respondent was not commonly known by the mark and
never applied for a license
or permission from Complainant to use the trademarked name); see also Gallup Inc. v. Amish Country Store, FA
96209 (Nat. Arb. Forum Jan. 23, 2001) (finding that Respondent does not have
rights in a domain name when Respondent is not known
by the mark).
Accordingly, the Panel finds that
Respondent has no rights or legitimate interests in the <trycelebrex.com> domain name; thus, Policy ¶ 4(a)(ii) has
been satisfied.
Registration and Use in Bad Faith
Policy paragraph 4(b) lists a set of
circumstances that represent bad faith use and registration. The Policy, however, expressly states that
the list of bad faith examples is without limitation. Therefore, the Panel is permitted to look at the totality of
circumstances upon determining the crucial bad faith issue. See Do The Hustle, LLC v. Tropic Web, D2000-0624 (WIPO Aug. 21, 2000) (“the
examples [of bad faith] in Paragraph 4(b) are intended to be illustrative,
rather than exclusive”);
see also Twentieth
Century Fox Film Corp. v. Risser, FA 93761 (Nat. Arb. Forum May 18, 2000)
(finding that in determining if a domain name has been registered in bad faith,
the Panel
must look at the “totality of circumstances”).
Respondent’s <trycelebrex.com> domain name contains Complainant’s fanciful
CELEBREX mark with the addition of the suggestive prefix “try.” The prefix is essentially a message that
encourages the use of Complainant’s product.
As such, it is evident that Respondent knew of Complainant’s CELEBREX
medication and Complainant’s interests in the CELEBREX mark. Hence, Respondent’s registration, despite
its awareness of Complainant’s interests, constitutes bad faith under Policy ¶
4(a)(iii). See Entrepreneur
Media, Inc. v. Smith, [2002] USCA9 115; 279 F.3d 1135, 1148 (9th Cir. Feb. 11, 2002) (finding that
"[w]here an alleged infringer chooses a mark he knows to be similar to
another, one can
infer an intent to confuse"); see also Samsonite Corp. v. Colony Holding, FA
94313 (Nat. Arb. Forum Apr. 17, 2000) (finding that evidence of bad faith
includes actual or constructive knowledge of a commonly
known mark at the time
of registration).
Respondent’s passive holding of the <trycelebrex.com> domain name
evidences bad faith registration and use.
It is established precedent that registering a domain name containing
another’s mark and holding it without a legitimate use for over
two years
constitutes bad faith registration and use.
See DCI S.A. v. Link
Commercial Corp., D2000-1232 (WIPO Dec. 7, 2000) (concluding that
Respondent’s passive holding of the domain name satisfies the requirement of ¶
4(a)(iii) of the Policy); see also Mondich
& Am. Vintage Wine Biscuits, Inc. v. Brown, D2000-0004 (WIPO Feb. 16,
2000) (holding that Respondent’s failure to develop its website in a two year
period raises the inference
of registration in bad faith); see also E. & J. Gallo Winery v. Oak Inv. Group,
D2000-1213 (WIPO Nov. 12, 2000) (finding bad faith where (1) Respondent knew or
should have known of Complainant’s famous GALLO
marks and (2) Respondent made
no use of the domain name <winegallo.com>).
The Panel finds that Policy ¶ 4(a)(iii)
has been satisfied.
DECISION
Having established all three elements
required under the ICANN Policy, the Panel concludes that the requested relief
shall be hereby
GRANTED.
Accordingly, it is Ordered that the
domain name <trycelebrex.com> be
TRANSFERRED from Respondent to Complainant.
James A. Carmody, Esq., Panelist
Dated: October 22, 2002
WorldLII:
Copyright Policy
|
Disclaimers
|
Privacy Policy
|
Feedback
URL: http://www.worldlii.org/int/other/GENDND/2002/1471.html